Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07015047 · ClinicalTrials.gov registry record · NA
Effects of Magnesium L-Threonate on Sleep, Recovery, and Athletic Performance in Collegiate Athletes
A NA study of Heart Rate Variability (HRV) and Athletic Performance, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07015047: Active NA study of Heart Rate Variability (HRV) and Athletic Performance, sponsored by University of California, Los Angeles.
NCT07015047 is a NA study of Heart Rate Variability (HRV) and Athletic Performance that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07015047, a NA study of Heart Rate Variability (HRV) and Athletic Performance, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing whether a special form of magnesium called magnesium L-threonate can help improve sleep quality, recovery, and physical performance in college athletes. Magnesium is important for muscle recovery and sleep, but many forms of it do not enter the brain well. Magnesium L-threonate is unique in that it can cross the blood-brain barrier and may improve deep and REM sleep, heart rate variability, and brain recovery. In this study, healthy UCLA varsity athletes aged 18 to 35 will be randomly assigned to take either magnesium L-threonate or a placebo each evening for 4 weeks. They will wear a WHOOP strap to track sleep, recovery, and heart rate data. Performance tests including jump height, grip strength, and reaction time will be completed before and after the 4-week period. This study will help researchers determine if this supplement can support recovery and training in athletes and whether wearable technology can help monitor these changes in real time.
Primary Outcome
Deep (slow-wave) sleep duration will be measured nightly using WHOOP wearable sensors. Average weekly deep sleep duration will be calculated and compared between groups.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Magnesium L-Threonate
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-07-15 |
| Phase | NA |
What the registry record for NCT07015047 still lists
NCT07015047 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Heart Rate Variability (HRV) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07015047 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07015047 about?
NCT07015047 is a clinical study titled "Effects of Magnesium L-Threonate on Sleep, Recovery, and Athletic Performance in Collegiate Athletes". This study is testing whether a special form of magnesium called magnesium L-threonate can help improve sleep quality, recovery, and physical performance in college athletes. Magnesium is important for muscle recovery and sleep, but many forms of it do not enter the brain well. Magnesium L-threonate...
What is the current status of trial NCT07015047?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-01. Estimated completion is 2026-07-15.
What conditions does trial NCT07015047 study?
This clinical trial studies the following conditions: Heart Rate Variability (HRV), Athletic Performance, Recovery of Function (G11.427.698.620).
What interventions are being tested in trial NCT07015047?
The interventions under investigation include: Placebo (OTHER), Magnesium L-Threonate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07015047?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07015047 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Rate Variability (HRV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07015047's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI